A thyroid medication interaction is any supplement pattern that can change the absorption of oral thyroid hormone replacement, alter endogenous thyroid hormone production, or shift the lab values used to titrate the prescription. The platform flags this category because routine supplements — minerals, fiber, and certain botanicals — can quietly change the dose-response of a prescription that is monitored on a months-long lab cadence.
Absorption-window overlap
Levothyroxine and related oral thyroid hormones are absorbed in a narrow window after dosing. Co-administered minerals — including calcium, iron, and magnesium — can bind the hormone in the gut and lower the absorbed fraction. The platform does not direct the user to change prescription timing on their own; it surfaces a one-line note that asks the pharmacist or prescriber how the existing schedule should accommodate any added mineral.
Iodine and selenium considerations
Iodine and selenium are inputs the thyroid uses to produce hormone, and supplemental intake can matter differently for users with thyroid disease than for users without a diagnosis. Users with diagnosed thyroid conditions — Hashimoto's, Graves', nodular disease — sit in a higher-caution tier where iodine flags are absolute rather than informational. See interaction risk for the tiering logic the platform applies once a thyroid diagnosis is in the profile.
Botanicals reported to affect the thyroid axis
Several botanicals have published reports or label-based reasons for thyroid review, including kelp-derived iodine concentrates, ashwagandha, and certain weight-loss stimulant formulas. The platform flags these against any thyroid prescription so the pair is reviewed by a clinician before activation.
For users assembling a roster alongside a thyroid prescription, the pillar overview at building your first supplement stack covers how the prescription field filters candidate supplements before the first shortlist is shown.
Lab interpretation effects
Some supplements can interfere with the assays used to measure TSH, free T4, or thyroid antibodies rather than with the hormone itself. Biotin at higher supplemental intakes is the most often-cited example in published lab guidance. A pharmacist or prescriber can advise on how to handle the supplement before a scheduled lab draw.
What to do when a flag fires
When a flag fires, the app keeps the new supplement from activating and prompts the user to bring the product label to a prescriber or pharmacist visit. The prescriber can confirm whether the schedule, supplement choice, or lab plan needs to change.
Limits of the screen
Published data on supplement plus thyroid prescription pairs is denser for absorption-window effects than for assay-level effects, and lab guidance updates as new assays come to market. The platform marks low-confidence flags explicitly rather than treating them as equivalent to well-studied ones.
How this appears in Unfair
A thyroid prescription in the user profile triggers a screen across minerals, iodine-bearing supplements, and assay-interfering compounds. Matched supplements are held with a question template pre-filled and the lab-cadence note is surfaced on the stack record.
Clinical safety note
New palpitations, heat or cold intolerance, unexplained weight change, or worsening fatigue on a thyroid plus supplement pair are reasons to involve a prescriber rather than continue and monitor on the platform alone.